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This study was performed with the purpose of testing the hypothesis that the high prevalence of hepatitis C among 
former athletes is associated with their past use of injectable stimulants. The study involved the participation of 
208 former professional and amateur soccer and basketball players from the region of Ribeirão Preto, Brazil, who 
answered a questionnaire regarding their exposure to risk factors, including the use of injectable stimulants in the 
time they were engaged in sporting activities. ELISA tests were used to detect infection by the hepatitis C virus, and 
confirmed with PCR and genotyping for the positive cases. It was observed that the former use of injectable stimu-
lants was a practice disseminated among the participants (24.5%), reaching 50.8% in the professionals. The overall 
prevalence for hepatitis C was 7.2%, with values of 11% among professionals and 5.5% among amateurs. In both 
categories, the presence of infection was markedly higher among those who admitted past use of injectable stimu-
lants when compared to those who denied such practice (36% and 0.8% among amateurs; 21.9% and 0% among 
professionals, respectively). Multivariate analysis showed that the use of those substances was the only variable 
associated with the risk of hepatitis C. This confirms previous observations, performed with reduced sample sizes 
and without comparison groups, which indicated that the use of injectable vitamins was a risk factor of hepatitis C 
among former athletes.
Keywords: hepatitis C - former athletes - injectable stimulants
to a change in medical practice in terms of anamnesis, 
since it would force the inclusion of questions regarding 
the former use of licit injections when practicing sports, 
an issue not considered relevant today.
Nevertheless, the hypothesis of hepatitis C being as-
sociated with the former use of injectable stimulants has 
never been appropriately researched in previous reports 
based on descriptive studies, a small number of partici-
pants, and without comparison groups. Thus, the need for 
a deeper investigation of the issue emerged. This study 
has the general objective of characterizing former ath-
letes who practiced sporting activities between 1960-1985 
in the region of Ribeirão Preto and Franca, state of São 
Paulo, Brazil, in terms of HCV infection and risk factor 
antecedents, particularly the use of injectable stimulants.
SUBJETCS, MATERIALS AND METHODS
An active search was performed for former soccer 
and basketball players who were engaged in sporting ac-
tivities in the region of Ribeirão Preto, as professionals 
or amateurs, between 1960-1985. The initial subject was 
a former internationally acknowledged soccer player, 
who is also a physician and lives in Ribeirão Preto. His 
participation made it easier for the researchers to make 
contact with former athletes of his generation. Partici-
pants were contacted either individually, after their iden-
tification and scheduling a meeting, or through visits at 
night or on weekends to places where former athletes 
meet to play their traditional recreational matches. Start-
ing with the identification of one or a group of former 
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Recently, observations at outpatient clinics have sug-
gested the probability of a higher risk of infection by the 
hepatitis B and C viruses, particularly the latter, among 
former athletes that practiced their activities between 
1950-1980. These observations are in accordance with 
sparse reports in the literature that pointed at a more fre-
quent distribution of hepatitis C among former athletes 
(Paraná et al. 1999, Souto et al. 2003). In an attempt to 
explain this finding, a hypothesis was formulated: that the 
use of injectable vitamin complexes and stimulants – a 
practice reported as common by individuals engaged in 
sporting activities some decades ago – could be account-
able for the dissemination of the hepatitis C virus (HCV), 
since the use of contaminated syringes and needles is one 
of the main known means of transmission of this agent 
(Heintges & Wands 1997, Shepard et al. 2005).
Verifying this hypothesis in an important public 
health issue considering it could identify a new risk 
group for hepatitis C and would allow for improved fo-
cus on this specific group. In the individual, it would lead 
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athletes, based on their indications of other fellows, the 
next step was to locate other potentially eligible individ-
uals, always using an active search strategy.
In every occasion, the study objectives and meth-
odology were explained to the potential participants, 
along with information about the essential health issues 
involving viral hepatitis, such as transmission mecha-
nisms, evolution, complications, treatment possibilities 
and the benefits of being diagnosed. The people who met 
the inclusion criteria and formally agreed to participate 
in the study, recorded by signing a free and informed 
consent form provided a 10 mL blood sample, which 
was collected by vein puncture using disposable ma-
terials. At the same time, a specific questionnaire was 
individually administered to obtain demographic data, 
information about their exposure to injectable vitamin 
complexes during the period they were engaged in sport-
ing activities and risk factors for viral hepatitis, particu-
larly the one caused by virus C. The blood samples were 
taken to the Serology Laboratory of the Clinic Hospital 
of the Ribeirão Preto Medical School where they were 
submitted to centrifugation and stored at -20ºC. After 
completing the collection, the samples were submitted 
to immunoenzyme tests for Hepatitis C (anti-HCV: Ax-
SYM HCV 3.0, Abbott, Wiesbaden, Germany).
The anti-HCV positive samples were submitted to 
HCV RNA detection by PCR (Cobas Amplicor; Roche, 
Manheim, Germany) and genotyping by a line probe 
assay (HCV Genotype assay, LiPA; Versant, Bayer, 
Tarrytown, NY, USA). The assays and interpretation 
of the results were performed following the manufac-
turers’ recommendations. The statistical analysis was 
performed by applying the log-binomial model (Skov et 
al. 1998), first testing the association between each pos-
sible independent variable and the presence of hepatitis 
C. The variables that show a p value smaller or equal to 
0.20 were submitted to a multivariate analysis, also us-
ing the log-binomial model.
The project was approved by the Research Ethics 
Committee of the Clinic Hospital of the Ribeirão Preto 
Medical School and data collection was performed be-
tween 2004-2007.
RESULTS
Of the 208 participants, the great majority (200) con-
sisted of former professional and amateur soccer play-
ers. The average age was 47.1 years, ranging from 37-76 
years. Table I shows the following findings: 
About 25% of participants (51) reported using inject-
able vitamin complexes/stimulants in the past, during 
the period they were engaged in sporting activities. Of 
these, 32 (50.8%) were professionals and 19 (13.1%) were 
amateurs (p < 0.0001). 
The overall positivity for infection by the HCV reached 
7.2% (CI 95%: 3.7-10.7) with values of 11.1% among pro-
fessionals (CI 95%: 3.4-18.9) and 5.5% among amateurs 
(CI 95%: 1.8-9.2). This difference was not considered sig-
nificant from a statistical point of view (p = 0.157).
A great difference was observed in hepatitis C posi-
tives among those who used injectable stimulants (14 or 
27.5%) and those who did not (1 or 0.6%). The statistical 
analysis revealed a strong association between the vari-
ables (p < 0.0001). These evident differences were pres-
ent in both the professionals (21.9% and 0%, respectively) 
and amateurs (36.8% and 0.8%, respectively).
Although a higher prevalence of hepatitis C was ob-
served among former athletes older than 40 years (com-
pared to younger ones) and those with over 10 years of 
sporting practice, there were no associations between 
those variables and a positive infection reported at the 
level of 5% (p values of 0.102 and 0.199, respectively).
The variables using injectable stimulants, professional 
category, age and time of sporting practice were submitted 
to a multivariate analysis through the application of the 
log-binomial model. The result is shown in Table II which 
shows that former use of injectable stimulants was the 
only variable shown to be an independent predictor of the 
risk of developing hepatitis C in the studied population.
Twelve HCV RNA positive samples were genotyped 
as genotype 1, subtypes 1a (n = 5) and 1b (n = 7) and 
three samples were genotype 3, subtype 3a. 
DISCUSSION
The supposition that the high number of hepatitis C 
cases currently observed among individuals that were 
TABLE I
Participants according to their category, use of injectable stimulants and positivity for hepatitis C among former athletes from 
Ribeirão Preto, state of São Paulo, Brazil, and region, 2008
                Hepatitis C         Positive Negative Total 
Category   Stimulants n % n % n % p 
Professionals Yes 7 21.9 25 78.1 32 100.0 
 No - - 31 100.0 31 100.0 0.01
  7 11.1 56 88.9 63 100.0 
Amateurs Yes 7 36.8 12 63.2 19 100.0 
 No 1 0.8 125 99.2 126 100.0 < 0.01
  8 5.5 137 94.5 145 100.0 
Total  15 7.2 193 92.8 208 100.0 
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once engaged in sporting activities could be associated 
with the use of injectable substances, with the purpose 
to increase their performance, emerged back in 1999, 
with the description of three cases of infection in former 
amateur soccer players in the state of Bahia (Paraná et 
al. 1999). Later, in 2003, there was a report about three 
positive cases among 40 former soccer players from the 
state of Mato Grosso, all having used injectable stim-
ulants in the past (Souto et al. 2003). In 2006, a news 
report published in the Folha de São Paulo newspaper 
(Roseguini 2006) reported that seven former members 
of the Próspera team, from the city of Criciúma (state 
of Santa Catarina), died due to complications caused 
by hepatitis C, in addition to others who were infected. 
Despite the one possible association, all these references 
resulted from descriptive studies, without comparison 
groups, and with very small sample sizes. As justified 
in one of the previous studies (Souto et al. 2003), the 
small number of individuals was due to the difficulties 
in locating and including potential participants. This 
problem was also experienced in the present study, as a 
considerable number of former athletes referred by their 
friends no longer lived in their original cities and their 
whereabouts were unknown. An additional factor was 
that several of them had already passed away, particu-
larly those that were engaged in sporting activities in the 
1960s and 1970s. For this reason, the study was spread to 
seven cities in the region of Ribeirão Preto and included 
a considerably greater number of participants than in 
the previous descriptions. The adopted methodology 
permitted, for the first time, an objective comparison of 
the risks between individuals with and without previous 
exposure to injectable substances.
The reported high frequency regarding the use of 
injectable substances with stimulant properties was re-
markable. Even considering the possibility of a bias de-
rived from the denial of its use by some former athletes, 
approximately one forth reported being exposed. The 
stated substances were all licit at the time the participants 
used them. Those substances included glucose, products 
commercialized under the brand names Tiaminose, En-
ergizan and, especially, Glucoenergan, reported by the 
vast majority as the most frequently used. This medica-
tion has fencamfamine as its base and was developed in 
the 1960s as an appetite suppressor. Its use was popu-
lar among the athletes of that period. According to the 
participants’ reports, it was administered in the locker 
room before matches or practice, either by their own ini-
tiative or from the masseur or another employee in the 
club. In a period before disposable syringes and needles 
appeared, these applications were performed with reus-
able material, which were submitted to the traditional 
boiling process between applications, even this minimal 
decontamination process often did not take place. Addi-
tionally, injections were applied subsequently in several 
individuals, using the same needle and syringe set.
The potential for hepatitis C transmission by these 
practices is evidenced by the prevalence of infection ob-
served among the participants, with a global value (7.2%) 
considerably more elevated than in the overall population. 
Moreover, it is evidenced by the astonishing differences 
between the prevalence observed in those exposed and 
those not exposed (27.5% and 0.6%, respectively). These 
differences are overwhelming between professionals as 
well as amateurs. After controlling the variables profes-
sional category, age and time of sporting practice, the ex-
posure to injectable substances has a predictor role inde-
pendent of the risk of developing hepatitis C.
Genotype 1 represented 80% of the positive samples, 
a percentage above those described for the states of Rio 
Grande do Sul, Santa Catarina (da Silva et al. 2007) and 
São Paulo, but similar to that observed in Southeast Bra-
zil (Campioto et al. 2005). This fact can be associated 
with the study field’s proximity to the state of Minas 
Gerais and the origin of several participants, from this 
and other states in the Southeast. The occurrence of gen-
otype 3 as the second most frequent is in agreement with 
findings verified in both Southeast and South Brazil, as 
well as in the country as a whole (da Silva et al. 2007, 
Botelho et al. 2008).
The findings of the present study substantially re-
inforce the association between the use of injectable 
substances in the past and hepatitis C among former 
athletes. This relationship assumes great sanitary im-
portance, as it leads to the identification of a new risk 
group for hepatitis C and should direct public health ac-
tion. Furthermore, it should justify a change in medical 
practice of patient anamnesis and approach. Until now, 
it has been common to associate hepatitis C exclusively 
with the use of illicit injectable substances and questions 
regarding the use of common licit injections in the past 
have been neglected. Based on the evidence collected so 
TABLE II
Multivariate analysis results through the log-binomial model, applied on former athletes from Ribeirão Preto, 
São Paulo, Brazil, and region, 2008
Variable Prevalence ratio Confidence interval (95%) p
Use of injectable stimulantsa 1.3276 1.2223-1.4420 < 0.0001
Professionals x amateursb 0.9691 0.8949-1.0494 0.440
Agec 1.0044 0.9403-1.0729 0.896
Time of sporting activityd 1.0687 0.9855-1.1589 0.108
a: 1: yes, 0: no; b: 1: professional, 0: amateur; c: 1: more than 40 years, 0: less than 40 years; d: 1: more than 10 years, 0: less 
than 10 years.
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far, there is a need to incorporate the question of past 
licit injections in the routine anamnesis of individuals 
that were engaged in sporting activities from 1960-1985 
and individuals that report an antecedent use of inject-
able stimulants should undergo serologic examination.
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